Bayer pays $7.25 billion to settle cancer claims from Roundup plaintiffs
Statements (10)
- Neutral
Bayer received approval for a billion-euro comparison to Glyphosat in the US
- Bearish
Bayer pays $7.25 billion in claims related to Roundup, a herbicide product.
- Neutral
Bayer is settling over 7.25 billion dollars in claims against users of Roundup.
- Neutral
US courts have approved a billion-dollar settlement between Bayer and glyphosate plaintiffs in the United States.
- Neutral
The EU judge approved Bayer's $7.025 billion settlement agreement for Roundup herbicide cases.
- Neutral
Brazilian Tribunal approved a US$ 7.25 billion agreement with Bayer for a cancer trial linked to a herbicide
- Neutral
Bayer is paying $7.25 billion to settle cancer claims from 65,000 people alleging Roundup causes cancer.
- Bearish
Bayer will pay up to $7.25 billion over two decades to resolve cancer claims from U.S. patients regarding Roundup.
- Neutral
Bayer will pay up to $7.25 billion over two decades to resolve thousands of claims from US cancer patients asserting the company should have warned people that its popular weedkiller Roundup could cause lymphoma.
- Neutral
Bayer's $7.25 billion roundup settlement has been approved by a judge